Background: Fecal microbiota transplant (FMT) is a potential treatment approach for many
diseases. Alzheimer's disease (AD) and cancer have been proven to have a specific …

Background The efficacy of fecal microbiota transplantation (FMT) as a therapeutic in
Alzheimer's disease was evaluated in the 5XFAD mouse model. Method We treated sixteen …

Traumatic brain injury (TBI) causes neuroinflammation and neurodegeneration, both of
which increase the risk and accelerate the progression of Alzheimer's disease (AD). The gut …

Alzheimer's disease (AD) is a neurodegenerative disease that causes memory and cognitive
decline. Although many studies have attempted to clarify the causes of AD occurrence, it is …

The efficacy of fecal microbiota transplantation (FMT) in Alzheimer's disease has yet to be
investigated. Here, we show that FMT is capable of providing neuroprotective effects in two …

Alzheimer's disease (AD) is the most common dementia in the elderly. Treatment for AD is
still a difficult task in clinic. AD is associated with abnormal gut microbiota. However, little is …

Several studies have confirmed that the pathophysiological progression of Alzheimer's
disease (AD) is closely related to changes in the intestinal microbiota; thus, modifying the …

Alzheimer's disease is a common neurological disorder, which has become one of the major
factors affecting human health due to its serious impact on individuals, families and society …

Background: The brain–gut axis has emerged as a potential target in neurodegenerative
diseases, including dementia, as individuals with dementia exhibit distinct gut microbiota …

After fecal microbiota transplantation (FMT) to treat Clostridioides difficile infection (CDI),
cognitive improvement is noticeable, suggesting an essential association between the gut …